Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Muscle Invasive Bladder Cancer × Genitourinary × Clear all

Phase

Phase NA 2 Phase 2 2 Phase 1 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 343 Carcinoma, Renal Cell 188 Urinary Bladder Neoplasms 108 Carcinoma, Non-Small-Cell Lung 89 Carcinoma, Transitional Cell 70 Melanoma 65 Ovarian Neoplasms 63 Kidney Neoplasms 63 Breast Neoplasms 62 Neoplasm Metastasis 60 Neoplasms 59 Colorectal Neoplasms 54 Squamous Cell Carcinoma of Head and Neck 46 Stomach Neoplasms 43 Uterine Cervical Neoplasms 39 Pancreatic Neoplasms 37 Triple Negative Breast Neoplasms 35 Lung Neoplasms 30 Esophageal Neoplasms 29 Endometrial Neoplasms 28 Non-Muscle Invasive Bladder Neoplasms 27 Carcinoma, Hepatocellular 26 Sarcoma 25 Head and Neck Neoplasms 23 Small Cell Lung Carcinoma 20 Colonic Neoplasms 16 Wilms Tumor 14 Metastatic Castration-resistant Prostate Cancer 14 Lymphoma 13 Glioblastoma 13

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04813107 2022-02-22

ANTICIPATE

Jiangsu Yahong Meditech Co., Ltd aka Asieris

Phase 1/2 Unknown

Muscle Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡